Viking Therapeutics, Inc. (VKTX)
28.99
+2.15
(+8.01%)
USD |
NASDAQ |
Nov 09, 16:00
28.66
-0.32
(-1.12%)
Pre-Market: 09:21
Viking Therapeutics Cash and Short Term Investments (Quarterly) : 959.81M for Sept. 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 959.81M |
| June 30, 2026 | 501.66M |
| March 31, 2026 | 602.96M |
| December 31, 2025 | 705.74M |
| September 30, 2025 | 714.57M |
| June 30, 2025 | 807.72M |
| March 31, 2025 | 851.86M |
| December 31, 2024 | 902.61M |
| September 30, 2024 | 930.44M |
| June 30, 2024 | 942.26M |
| March 31, 2024 | 962.98M |
| December 31, 2023 | 362.08M |
| September 30, 2023 | 376.24M |
| June 30, 2023 | 392.92M |
| March 31, 2023 | 135.66M |
| December 31, 2022 | 155.48M |
| September 30, 2022 | 155.02M |
| June 30, 2022 | 168.92M |
| March 31, 2022 | 184.90M |
| December 31, 2021 | 202.10M |
| September 30, 2021 | 216.14M |
| June 30, 2021 | 228.26M |
| March 31, 2021 | 241.68M |
| December 31, 2020 | 248.39M |
| September 30, 2020 | 255.30M |
| Date | Value |
|---|---|
| June 30, 2020 | 263.00M |
| March 31, 2020 | 269.16M |
| December 31, 2019 | 275.64M |
| September 30, 2019 | 288.07M |
| June 30, 2019 | 292.64M |
| March 31, 2019 | 298.72M |
| December 31, 2018 | 301.52M |
| September 30, 2018 | 304.16M |
| June 30, 2018 | 142.17M |
| March 31, 2018 | 77.47M |
| December 31, 2017 | 20.58M |
| September 30, 2017 | 9.839M |
| June 30, 2017 | 12.08M |
| March 31, 2017 | 12.31M |
| December 31, 2016 | 13.15M |
| September 30, 2016 | 14.62M |
| June 30, 2016 | 17.20M |
| March 31, 2016 | 11.25M |
| December 31, 2015 | 14.10M |
| September 30, 2015 | 17.49M |
| June 30, 2015 | 21.66M |
| March 31, 2015 | 0.327M |
| December 31, 2014 | |
| September 30, 2014 | |
| June 30, 2014 | 0.8915M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Eli Lilly & Co. | 4.885B |
| Ironwood Pharmaceuticals, Inc. | 86.38M |
| Compass Therapeutics, Inc. | -- |
| Structure Therapeutics, Inc. | 1.343B |
| Amgen, Inc. | 13.19B |